High parathyroid hormone, but not low vitamin D concentrations, expose elderly inpatients to hypertension

Geriatrics and Gerontology International

Volumn 13, Issue 3, 2013, Pages 783-791

  Mateus Hamdan, Leyla ^a,c,d   Beauchet, Olivier ^a,c,d   Bouvard, Béatrice ^b,c   Legrand, Erick ^b,c   Fantino, Bruno ^a,c,d,e   Annweiler, Cédric ^a,c,d,f,g  

^a Departments of Neuroscience   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d UNIVERSITÉ D'ANGERS   (France)

^e Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

^f ST JOSEPH S HEALTH CENTRE   (Canada)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Blood pressure; Hypertension; Older adults; Parathyroid hormone; Vitamin D

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; CREATININE; PARATHYROID HORMONE; THYROTROPIN; VITAMIN D;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CAUCASIAN; CHRONIC DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; FRANCE; GERIATRICS; HOSPITAL PATIENT; HUMAN; HYPERTENSION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THYROTROPIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

BLOOD PRESSURE; HYPERTENSION; OLDER ADULTS; PARATHYROID HORMONE; VITAMIN D;

AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INPATIENTS; MALE; PARATHYROID HORMONE; RETROSPECTIVE STUDIES; VITAMIN D;

EID: 84880036016     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2012.00945.x     Document Type: Article

References (39)

1. Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation 2000; 101: 329-335.
2. Merke J, Hofmann W, Goldschmidt D, Ritz E. Demonstration of 1, 25(OH)2 vitamin D3 receptor and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 1987; 41: 112-114.
3. Jiang B, Morimoto S, Yang J, Niioabu T, Fukuo K, Ogihara T. Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J Cardiovasc Pharmacol 1998; 31: S142-S144.
4. Jorde R, Svartberg J, Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in males. J Hypertens 2005; 35: 1639-1644.
5. Snijder MB, Lips P, Seidell JC etal. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 2007; 261: 558-565.
6. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E. Serum 25-hydroxycholecalciferol concentration in newly detected hypertension. Am J Hypertens 1995; 8: 429-432.
7. Chapuy MC, Preziosi P, Maamer M etal. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997; 7: 439-443.
8. Pickering TG, Hall JE, Appel LJ etal. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111: 697-716.
9. Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O. Vitamin D in the elderly: 5 points to remember. Geriatr Psychol Neuropsychiatr Vieil 2011; 9: 259-267.
10. Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 2005; 35: 290-304.
11. Jorde R, Bønaa KH, Sundsjford J. Population based study on serum ionised calcium, serum parathyroid hormone, and blood pressure. The Tromsø study. Eur J Endocrinol 1999; 141: 350-357.
12. Lind L, Ridefelt P, Rastad J, Akerstrom G, Ljunghall S. Relationship between abnormal regulation of cytoplasmic calcium and elevated blood pressure in patients with primary hyperparathyroidism. J Hum Hypertens 1994; 8: 113-114.
13. Heyliger A, Tangpricha V, Weber C, Sharma J. Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism. Surgery 2009; 146: 1042-1047.
14. Broulik PD, Brouliková A, Adámek S etal. Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism. Int J Endocrinol 2011; 2011: 309068.
15. Schiffl H, Lang SM. Hypertension secondary to PHPT: cause or coincidence? Int J Endocrinol 2011; 2011: 974647.
16. Neuser D, Schulte-Brinkmann R, Kazda S. Development of hypertension in WKY rats after transplantation of parathyroid glands from SHR/SP. J Cardiovasc Pharmacol 1990; 16: 971-974.
17. Taylor EN, Curhan GC, Forman JP. Parathyroid hormone and the risk of incident hypertension. J Hypertens 2008; 26: 1390-1394.
18. Hanson AS, Linas SL. Parathyroid hormaone/adenylate cyclase coupling in vascular smooth muscle cells. Hypertension 1994; 23: 468-475.
19. Jespersen B, Randlov A, Abrahamsen J, Fogh-Andersen N, Kanstrup IL. Effect of PTH(1-34) on blood pressure, renal function, and hormones in essential hypertension. The altered pattern of reactivity may counteract raised blood pressure. Am J Hypertens 1997; 10: 1356-1367.
20. Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 1986; 2: 360-370.
21. Gennari C, Nami R, Gonneli S. Hypertension and primary hyperparathyroidism: the role of adrenaline and renin-angiotensin systems. Miner Electrolyte Metab 1995; 21: 77-81.
22. Grant FD, Mandel SJ, Brown EM, Williams GH, Seely EW. Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab 1992; 75: 988-992.
23. Brunaud L, Germain A, Zarnegar R etal. Serum aldosterone is correlated positively to parathyroid hor- mone (PTH) levels in patients with primary hyperparathyroidism. Surgery 2009; 146: 1035-1041.
24. Nilsson IL, Rastad J, Johansson K, Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001; 130: 986-990.
25. Schlieffer R, Bukoski RD. Involvement of endothelium in contractile response of resistance arteries in parathyroidectomized SHR. Am J Hypertens 1990; 3: 87A.
26. Kosch M, Hausberg M, Vormbrock K etal. Impaired flow-mediated vasodilatation of the brachial artery in patients with primary hyperparathroidism improves after parathyroidectomy. Cardiovasc Res 2000; 47: 813-818.
27. Pang PK, Lewanczuk RZ, Benishin CG. Parathyroid hypertensive factor. J Hypertens 1990; 8: S155-S159.
28. Klar J, Sigl M, Obermayer B, Schweda F, Krämer BK, Kurtz A. Calcium inhibits renin gene expression by transcriptional and posttranscriptional mechanisms. Hypertension 2005; 46: 1340-1346.
29. McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch M, Krutzik S. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 1980; 2: 162-168.
30. Holick MF, Chen TC. Vitamin D deficiency: a wordwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080-1086.
31. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1, 25-dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensine system. J Clin Invest 2002; 110: 229-238.
32. Martins D, Wolf M, Pan D etal. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. Arch Intern Med 2007; 167: 1159-1165.
33. Wang TJ, Pencina MJ, Booth S etal. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-511.
34. Pittas AG, Chung M, Trikalinos T etal. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314.
35. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009; 27: 1948-1954.
36. Calver A, Collier J, Vallance P. Nitric-oxide and cardiovascular control. Exp Physiol 1993; 78: 303-326.
37. Bevers LM, van Faassen EE, Vuong TD etal. Low albumin levels increase endothelial NO production and decrease vascular NO sensitivity. Nephrol Dial Transplant 2006; 21: 3443-3449.
38. Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens 2006; 8: 596-599.
39. Cappuccio FP, Elliott P, Allender PS, Pryer J, Follman DA, Cutler JA. Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. Am J Epidemiol 1995; 142: 935-945.